{
    "2018-09-26": [
        [
            {
                "time": "2018-09-01",
                "original_text": "Pfizer’s Revenue and EPS Growth Rate",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Revenue",
                        "EPS",
                        "Growth Rate"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "What’s Driving Pfizer’s Revenue?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Revenue",
                        "Driving"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "Dow Movers: NKE, IBM",
                "features": {
                    "keywords": [
                        "Dow",
                        "Movers",
                        "NKE",
                        "IBM"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "A Look at Pfizer’s Performance So Far in September",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Performance",
                        "September"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-27",
                "original_text": "Prestige Consumer Healthcare Inc. (PBH) Ex-Dividend Date Scheduled for September 27, 2018",
                "features": {
                    "keywords": [
                        "Prestige",
                        "Consumer",
                        "Healthcare",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "Analyzing Perrigo’s Prescription Pharmaceuticals Business",
                "features": {
                    "keywords": [
                        "Perrigo",
                        "Prescription",
                        "Pharmaceuticals",
                        "Business"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "A Closer Look at the Allergan–Bonti Deal",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Bonti",
                        "Deal"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}